DR Agarwals Health Care L
NSE: AGARWALEYE · Hospital · sector
₹475.25NSE close 2026-10-26
Key numbers
Market cap₹15,065 cr
Price₹475.25
52w high / low₹568 / ₹401
P/E101.3xSector median 42.5x
P/B7.4xSector median 4.9x
Book value₹63.9
Dividend yield0.01%Sector median 0.17%
ROE7.6%Sector median 12.1%
ROCE16.5%Sector median 13.8%
OPM27.8%Sector median 20.3%
Debt / equity0.08xSector median 0.24x
EV/EBITDA24.4xSector median 23.6x
Interest cover4.0x
Current ratio1.24x
Sales growth 3y–Sector median +14.1%
Profit growth 3y–Sector median +14.7%
PEG–
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 32 companies in Hospital (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹282 cr vs borrowings ₹157 cr (FY26): cash is higher (net cash).
- Operating profit covered interest 4.0x in the last 12 months.
- Other income was 25% of net profit in the last 12 months.
- No dividend in the last 2 financial years.
- Price ₹475.25 on 2026-10-26: -16.3% from the 52-week high, +18.5% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹545.70 · low ₹336.75
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | 431 | 460 | 487 | 499 | 530 | 564 | 614 |
| EBITDA | 115 | 128 | 128 | 136 | 144 | 163 | 170 |
| OPM % | 26.7% | 27.9% | 26.2% | 27.3% | 27.2% | 28.9% | 27.8% |
| Other income | 13 | 15 | 13 | 8 | 11 | 13 | 6 |
| Net profit | 22 | 33 | 30 | 30 | 34 | 40 | 45 |
| EPS (₹) | 0.73 | 1.04 | 0.95 | 0.94 | 1.07 | 1.25 | 1.43 |
| Revenue YoY | +23.0% | +22.6% | +26.0% | ||||
| Profit YoY | +51.0% | +21.9% | +50.5% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY25 | FY26 | TTM |
|---|---|---|---|
| Revenue | 1,711 | 2,080 | 2,207 |
| EBITDA | 453 | 571 | 613 |
| Net profit | 83 | 133 | 148 |
| EPS (₹) | 2.80 | 4.21 | 4.69 |
| Revenue growth | +21.6% | – | |
| Profit growth | +59.6% | – | |
| Dividend / share (₹) | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | – | – | – |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | – (2y) | -14.4% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 1,867 | 2,025 |
| Borrowings | 247 | 157 |
| Cash & equivalents | 522 | 282 |
| Total assets | 3,672 | 3,942 |
| Fixed assets | 708 | 926 |
| Capital work in progress | 144 | 234 |
| Investments | 0 | 0 |
| Receivables | 124 | 161 |
| Inventory | 80 | 94 |
| Payables | 153 | 149 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | 360 | 519 |
| Cash from investing | -750 | -308 |
| Cash from financing | 382 | -220 |
| Capex | 321 | 461 |
| Free cash flow | 39 | 58 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | 4.5% | 6.6% |
| ROCE % | 12.7% | 15.5% |
| Debtor days | 26 | 28 |
| Inventory days | 181 | 178 |
| Payable days | 345 | 283 |
| Cash conversion cycle (days) | -138 | -77 |
| Working capital days | 67 | 20 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 32.33% |
| FIIs | 49.56% |
| DIIs | 15.87% |
| of which Mutual funds | 14.18% |
| of which Insurance | 1.06% |
| Government | 0.00% |
| Public (non-institutions) | 2.24% |
| Quarter | Feb 2025 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 32.45% | 32.45% | 32.42% | 32.42% | 32.39% | 32.36% | 32.34% | 32.33% |
| Promoter group | % |
|---|---|
| Athiya Agarwal | 4.45% |
| Amar Agarwal | 4.45% |
| Ashar Agarwal | 4.45% |
| Ashvin Agarwal | 4.45% |
| Adil Agarwal | 4.43% |
| Adil Agarwal, Anosh Agarwal, Ashvin Agarwal | 4.27% |
| Anosh Agarwal | 4.23% |
| DR. Agarwal's EYE Institute (P) Limited | 1.37% |
| A Urmila | 0.23% |
| Farah Agarwal | 0.00% |
| Rambha Seth | 0.00% |
| Kaamna Kakkar | 0.00% |
| Tejeshwar Seth | 0.00% |
| Kamalesh Kumar Seth | 0.00% |
| Muktha Seth | 0.00% |
| Public holders above 1% | % |
|---|---|
| Hyperion Investments PTE. Ltd. | 15.47% |
| Arvon Investments Pte.ltd. | 9.87% |
| Government of Singapore | 6.16% |
| Invesco India Flexi CAP Fund | 5.52% |
| Claymore Investments (Mauritius) PTE. Ltd | 5.17% |
| ICICI Prudential Healthcare Fund | 5.06% |
| Polar Capital Funds PLC - Healthcare Opportunities | 2.76% |
| Motilal Oswal S&P BSE Healthcare ETF | 1.59% |
| Franklin Templeton Investment Funds - Franklin IND | 1.36% |
| Monetary Authority of Singapore | 1.23% |
| Axis MAX Life Insurance Limited A/C - Ulif01311/02 | 1.06% |
42,055 shareholders. Pledged: – of promoter shares.
Peers in Hospital
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | ₹1,12,797 cr | 54.0x | 11.9x | 23.6% | 21.8% | 15.1% | +14.9% | 0.26% |
| MAXHEALTH | ₹81,266 cr | 55.7x | 7.6x | 14.5% | 13.8% | 26.1% | +22.4% | 0.18% |
| MANIPALHOS | ₹73,581 cr | – | – | – | – | – | – | – |
| FORTIS | ₹55,467 cr | 52.9x | 5.6x | 11.1% | 13.2% | 22.2% | +13.2% | 0.14% |
| NH | ₹33,971 cr | 41.4x | 7.5x | 20.0% | 13.7% | 18.7% | +20.4% | 0.26% |
| ASTERDM | ₹33,523 cr | 104.7x | 7.3x | 8.0% | 12.8% | 16.7% | -27.0% | 0.16% |
| MEDANTA | ₹32,575 cr | 58.5x | 8.2x | 15.1% | 15.8% | 20.5% | +17.9% | 0.04% |
| KIMS | ₹28,123 cr | 131.3x | 12.5x | 9.3% | 9.6% | 19.5% | +21.1% | 0.74% |
| AGARWALEYE | ₹15,065 cr | 101.3x | 7.4x | 7.6% | 16.5% | 27.8% | – | 0.01% |
| RAINBOW | ₹11,802 cr | 41.3x | 7.2x | 18.3% | 27.4% | 31.5% | +13.2% | 0.26% |
Documents
- Annual report FY26
- Annual report FY25
- Announcements NSE filings
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
| Sector | Healthcare |
| Industry | Hospital |
| Sub-industry | Hospital |
| Symbol | AGARWALEYE |
| BSE code | 544350 |
| ISIN | INE943P01029 |
| Face value | ₹1.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.